Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
eNq1mF1v2jAUhu/5FVHuSUhbVjoFqo21G1KrMVq0aTeVSQ5gFuzUx+Zjv34OoVtaOepq8GV8nNcnPsePXyW+3CwzbwUCKWddPwpavgcs4Slls64/vr9udvzLXiNekBWpTDsPWkF04ntJRhC7fhENJkAYBj9ubz6Bfh+E32t4MZ8sIJHP5ilJs+ALwfktyYs5XrziNPWWIOc87fq5krtRL0YpdBa9NRe/MCcJxOF+pBpdPJxVx+OwEPsPVYUgbgibGUWBWWkmSghgsk8kzLjY1uR7aqVNcQTIlUhgSOR8KPiKppAal5iSDMFqkek6vQOxykAWixjFw0WyRCtxsiCbETwOzEl/0NG+3Mhmqxmdn1202p2TdhRFdsUVla0yV0F/RJjnIn04uei0T1vtEFhIWRFE0pSAkqMEwRlYFmvIhSSZozJR7D/vNEfrCHh8tR1SinlGtsECc9utIoLoMAjNA3cfUnzBvdCEyvSevdBnKsvCN2Y93vPDUcYFnvpc6Y40Y+R6ZLsRfc4kbOorakc+udn3IgU8nuzvFwfwb2CoJhlNbBmnKaT0ER+PBvWIc0qHjwRhLNzh4TtlKV/j8bFTLbOj7PMdOY2iuiJRUZJ3Ubttfap+6rLV3EFXSvAcQg0kiodwZsCm/FDC6DY1Sz01qbv+3FkjnpAMasxR05I+ujGfvJyz1nd3rMqAUfTz1b1tv3xTILZ3u0ejNE271Urb0dkF8nWD1ub+9nYvT70T56yEmSZzKXN8H4br9TqYE2wi0bsUTIV7/FeuYHdG3sk9X/qeEqGOUp+Ud+PbSmZ7+l5zAoe62/37exdtXEMKBQfUogS1M5wOro5P6H/W1lnaw2c4cbfMzoYSSTlz5YbUxGyFDr0TdGnZtWaY/Dqd0pp/K7WtGYflf51eIw6Lfzq9xh/HfgQX
dffPqe72VysNqQCx